Global BioDevelopment (Global BDI) provides pharmaceutical development and consulting services to take drugs from formula through IND submission and beyond. Development programs are designed, implemented and managed by industry experts to give the best quality for your budgetary dollar.
Global BDI has expertise in many phases of preclinical pharmaceutical development across multiple therapeutic areas including oncology, anti-infectives, endocrinology, CNS, cardiovascular and inflammation. We have experience working with small molecules, recombinant proteins, monoclonal antibodies, oligonucleotides and cancer vaccines.
The business development arm specializes in working with small to mid-sized organizations assisting in the planning and execution of drug research and development.
For additional information, please contact UpReach.